Dofetilide GudangMovies21 Rebahinxxi LK21

      Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 μg of dofetilide. It is not available in Europe or Australia.


      Medical uses


      Dofetilide is used for the maintenance of sinus rhythm in individuals prone to the occurrence of atrial fibrillation and flutter arrhythmias, and for chemical cardioversion to sinus rhythm from atrial fibrillation and flutter.
      Based on the results of the Danish Investigations of Arrhythmias and Mortality on Dofetilide ("DIAMOND") study, dofetilide does not affect mortality in the treatment of patients post-myocardial infarction with left ventricular dysfunction, however it was shown to decrease all-cause readmissions as well as CHF-related readmissions. Because of the results of the DIAMOND study, some physicians use dofetilide in the suppression of atrial fibrillation in individuals with LV dysfunction, however use appears limited: After initially receiving marketing approval in Europe in 1999, Pfizer voluntarily withdrew this approval in 2004 for commercial reasons and it is not registered in other first world countries.
      It has clinical advantages over other class III antiarrhythmics in chemical cardioversion of atrial fibrillation, and maintenance of sinus rhythm, and does not have the pulmonary or hepatotoxicity of amiodarone, however atrial fibrillation is not generally considered life-threatening, and dofetilide causes an increased rate of potentially life-threatening arrhythmias in comparison to other therapies.


      Contraindications


      Prior to administration of the first dose, the corrected QT (QTc) must be determined. If the QTc is greater than 440 msec (or 500 msec in patients with ventricular conduction abnormalities), dofetilide is contraindicated. If heart rate is less than 60 bpm, the uncorrected QT interval should be used. After each subsequent dose of dofetilide, QTc should be determined and dosing should be adjusted.
      If at any time after the second dose of dofetilide the QTc is greater than 500 msec (550 msec in patients with ventricular conduction abnormalities), dofetilide should be discontinued.


      Adverse effects


      Torsades de pointes is the most serious side effect of dofetilide therapy. The incidence of torsades de pointes is 0.3-10.5% and is dose-related, with increased incidence associated with higher doses. The majority of episodes of torsades de pointes have occurred within the first three days of initial dosing. Patients should be hospitalized and monitored for the first three days after starting dofetilide.
      The risk of inducing torsades de pointes can be decreased by taking precautions when initiating therapy, such as hospitalizing individuals for a minimum of three days for serial creatinine measurement, continuous telemetry monitoring and availability of cardiac resuscitation.


      Pharmacology




      = Mechanism of action

      =
      Dofetilide works by selectively blocking the rapid component of the delayed rectifier outward potassium current (IKr).
      This causes the refractory period of atrial tissue to increase, hence its effectiveness in the treatment of atrial fibrillation and atrial flutter.
      Dofetilide does not affect dV/dTmax (the slope of the upstroke of phase 0 depolarization), conduction velocity, or the resting membrane potential.

      There is a dose-dependent increase in the QT interval and the corrected QT interval (QTc). Because of this, many practitioners will initiate dofetilide therapy only on individuals under telemetry monitoring or if serial EKG measurements of QT and QTc can be performed.


      = Pharmacokinetics

      =
      Peak plasma concentrations are seen two to three hours after oral dosing when fasting. Dofetilide is well absorbed in its oral form, with a bioavailability of >90%. Intravenous administration of dofetilide is not available in the United States.
      The elimination half-life of dofetilide is roughly 10 hours; however, this varies based on many physiologic factors (most significantly creatinine clearance), and ranges from 4.8 to 13.5 hours. Due to the significant level of renal elimination (80% unchanged, 20% metabolites), the dose of dofetilide must be adjusted to prevent toxicity due to impaired renal function.
      Dofetilide is metabolized predominantly by CYP3A4 enzymes predominantly in the liver and GI tract. This means that it is likely to interact with drugs that inhibit CYP3A4, such as erythromycin, clarithromycin, or ketoconazole, resulting in higher and potentially toxic levels of dofetilide.


      Metabolism


      A steady-state plasma level of dofetilide is achieved in 2–3 days.
      80% of dofetilide is excreted by the kidneys, so the dose of dofetilide should be adjusted in individuals with chronic kidney disease, based on creatinine clearance.
      In the kidneys, dofetilide is eliminated via cation exchange (secretion). Agents that interfere with the renal cation exchange system, such as verapamil, cimetidine, hydrochlorothiazide, itraconazole, ketoconazole, prochlorperazine, and trimethoprim should not be administered to individuals taking dofetilide.
      About 20 percent of dofetilide is metabolized in the liver via the CYP3A4 isoenzyme of the cytochrome P450 enzyme system. Drugs that interfere with the activity of the CYP3A4 isoenzyme can increase serum dofetilide levels. If the renal cation exchange system is interfered with (as with the medications listed above), a larger percentage of dofetilide is cleared via the CYP3A4 isoenzyme system.


      History


      After its initial US FDA approval, due to the pro-arrhythmic potential, it was only made available to hospitals and prescribers that had received education and undergone specific training in the risks of treatment with dofetilide; however, this restriction was subsequently removed in 2016.


      See also


      Antiarrhythmic agents
      Cardiac action potential
      Electrocardiogram


      References

    Kata Kunci Pencarian:

    dofetilidedofetilide tabletdofetilide mimsdofetilide pronunciationdofetilide usesdofetilide brand namedofetilide moadofetilide costdofetilide warningsdofetilide dosage
    Dofetilide Capsules | Sigmapharm Laboratories, LLC

    Dofetilide Capsules | Sigmapharm Laboratories, LLC

    Dofetilide Capsules | Sigmapharm Laboratories, LLC

    Dofetilide Capsules | Sigmapharm Laboratories, LLC

    Dofetilide | CAS 115256-11-6 | P212121 Store

    Dofetilide | CAS 115256-11-6 | P212121 Store

    APExBIO - Dofetilide

    APExBIO - Dofetilide

    APExBIO - Dofetilide

    APExBIO - Dofetilide

    Dofetilide Capsules - Accord Healthcare

    Dofetilide Capsules - Accord Healthcare

    Dofetilide – Drug Approvals International

    Dofetilide – Drug Approvals International

    Dofetilide – Drug Approvals International

    Dofetilide – Drug Approvals International

    Dofetilide – Drug Approvals International

    Dofetilide – Drug Approvals International

    Dofetilide

    Dofetilide

    Dofetilide - brand name list from Drugs.com

    Dofetilide - brand name list from Drugs.com

    Dofetilide

    Dofetilide

    Search Results

    dofetilide

    Daftar Isi

    Wiki Tikosyn/Dofetilide CPT codes??? - AAPC

    May 12, 2014 · I am looking for help regarding the 3 day administration of Tikosyn/Dofetilide in the hospital setting. I have never heard of this till now and need help with the physician side of the CPT codes. I have researched online and have come up empty for the most part. I am aware that certain cpt codes...

    Accidentally Took Two Doses of Dofetilide: What to Do Next?

    Customer: I accidentally took 2 doses of dofetilide 500mcg 2 hours apart. Do I need to worry? The first dose was 10:30pm, the 2nd dose was at 12:30am. Doctor's Assistant: The Pharmacist can help. Just a couple quick questions before I transfer you. When was this?

    Expert Answers on Dofetilide, CBD Oil, and Other Drug Interactions

    Thanks for your reply. An interaction checker shows no conflicts with dofetilide and CBD. There is theoretical suggestions that Dofetilide levels can increase when taking CBD, but this has not been proven in patients. Of your other medicines, crestor and CBD are both processed by the liver.

    Accidentally Took Extra Dofetilide Dose - Expert Advice

    Disclaimer: Information in questions, answers, and other posts on this site ("Posts") comes from individual users, not JustAnswer; JustAnswer is not responsible for Posts.

    Can I take guaifenesin when I am on dofetilide. Along with …

    Customer: along with dofetilide I take Eliquis and metoprolol Doctor's Assistant: Anything else in your medical history you think the Doctor should know? Customer: I have a pacemaker Answered by Dr. Bridget in 1 min 4 years ago

    Is Mucinex and Zicam OK to use while taking Dofetilide (Tiikosyn)?

    Hello!And, thanks for your question. I'm DrMike, a pharmacist with over 20 year’s experience, and I'm glad to help you today.

    I took my regular dose of Tikosyn (DOFETILIDE) AND THEN

    Customer: I took my regular dose of Tikosyn (DOFETILIDE) AND THEN TOOK ANOTHER dose 125mg at 11:30. This medication is taken every 12 hours. This medication is taken every 12 hours. I had I’d in my container with the days marked thinking it was Sunday.

    Expert Answers on Stopping Tikosyn and Its Side Effects

    Disclaimer: Information in questions, answers, and other posts on this site ("Posts") comes from individual users, not JustAnswer; JustAnswer is not responsible for Posts.

    What to Do If Your Dog Ate a Dofetilide 500 mg Capsule

    Customer: I think my dog just ate my dofetilide 500 MG capsule. What do I do? Veterinarian's Assistant: I'll do all I can to help. How much does the dog weigh? Customer: 18 lbs Veterinarian's Assistant: When was this? Has the dog thrown up since then? Customer: About 5 …

    WHAT DO I NEED TO KNOW ABOUT DOFETILIDE? USES, …

    Dofetilide is in a class of medications called antiarrhythmics. These medications alter the electrical signaling pathways in the heart in order to normalize irregular heartbeats. A-fib is one type of irregular heartbeat. Specifically with dofetilide, the dosing and timing is extremely sensitive.